Abbreviation
|
Formula
|
Mass
|
Main Class
|
Sub Class
|
Galα1-4Galβ1-4Glcβ-Cer 34:1;O2
|
C52H97NO18
|
1023.670570
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-4Galβ1-4Glcβ-Cer 36:1;O2
|
C54H101NO18
|
1051.701871
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-4Galβ1-4Glcβ-Cer 38:1;O2
|
C56H105NO18
|
1079.733171
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-4Galβ1-4Glcβ-Cer 40:1;O2
|
C58H109NO18
|
1107.764471
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-4Galβ1-4Glcβ-Cer 42:2;O2
|
C60H111NO18
|
1133.780121
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-4Galβ1-4Glcβ-Cer 42:1;O2
|
C60H113NO18
|
1135.795771
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-4Galβ1-4Glcβ-Cer 44:2;O2
|
C62H115NO18
|
1161.811421
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-4Galβ1-4Glcβ-Cer 44:1;O2
|
C62H117NO18
|
1163.827071
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2
|
C58H107NO23
|
1185.723396
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2
|
C58H107NO23
|
1185.723396
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2
|
C60H111NO23
|
1213.754696
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2
|
C60H111NO23
|
1213.754696
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2
|
C60H110N2O23
|
1226.749944
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2
|
C60H110N2O23
|
1226.749944
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2
|
C62H115NO23
|
1241.785996
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2
|
C62H115NO23
|
1241.785996
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2
|
C62H114N2O23
|
1254.781245
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2
|
C62H114N2O23
|
1254.781245
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2
|
C64H119NO23
|
1269.817296
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2
|
C64H119NO23
|
1269.817296
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2
|
C64H118N2O23
|
1282.812545
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2
|
C64H118N2O23
|
1282.812545
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2
|
C66H121NO23
|
1295.832946
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2
|
C66H121NO23
|
1295.832946
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2
|
C66H123NO23
|
1297.848596
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2
|
C66H123NO23
|
1297.848596
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2
|
C66H122N2O23
|
1310.843845
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2
|
C66H122N2O23
|
1310.843845
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2
|
C68H125NO23
|
1323.864246
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2
|
C68H125NO23
|
1323.864246
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2
|
C68H127NO23
|
1325.879896
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2
|
C68H127NO23
|
1325.879896
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Fucα1-2Galα1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2
|
C64H117NO27
|
1331.781306
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2
|
C68H124N2O23
|
1336.859495
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2
|
C68H124N2O23
|
1336.859495
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2
|
C68H126N2O23
|
1338.875145
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2
|
C68H126N2O23
|
1338.875145
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2
|
C64H117NO28
|
1347.776221
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Fucα1-2Galα1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2
|
C66H121NO27
|
1359.812606
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2
|
C70H128N2O23
|
1364.890795
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2
|
C70H128N2O23
|
1364.890795
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2
|
C70H130N2O23
|
1366.906445
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2
|
C70H130N2O23
|
1366.906445
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2
|
C66H121NO28
|
1375.807521
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Fucα1-2Galα1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2
|
C68H125NO27
|
1387.843906
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-4GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2
|
C66H120N2O28
|
1388.802770
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2
|
C66H120N2O28
|
1388.802770
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 34:1;O2
|
C66H120N2O28
|
1388.802770
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
GalNAcβ1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2
|
C66H120N2O28
|
1388.802770
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|
Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2
|
C68H125NO28
|
1403.838821
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
|